001     6512
005     20200402205709.0
024 7 _ |2 WOS
|a WOS:000270000500006
037 _ _ |a PreJuSER-6512
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
084 _ _ |2 WoS
|a Biophysics
100 1 _ |0 P:(DE-HGF)0
|a Mangels, C.
|b 0
245 _ _ |a Binding of TCA to the prion protein: mechanism, implication for therapy, and application as probe for complex formation of bio-macromolecules
260 _ _ |a Guilderland, NY
|b Adenine Press
|c 2009
300 _ _ |a 163 - 170
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 16381
|a Journal of Biomolecular Structure & Dynamics
|v 27
|x 0739-1102
|y 2
500 _ _ |a We thank Dr. Vilma Martins for providing a plasmid with the human PRNP-gene. Financial support from the Bavarian Prion Research Platform (ForPrion) and the Volkswagen-Stiftung (1/79968) is gratefully acknowledged.
520 _ _ |a Tricyclic aromatic compounds (TCA) are promising candidates for treatment of transmissible spongiform encephalopathies. Direct binding to the cellular prion protein (PrPC) has been proposed as anti-prion active mechanism. We here show by means of NMR-spectroscopy that binding of TCA occurs with millimolar affinity to motifs consisting of two neighboring aromatic residues (Ar-Ar motif). It is independent of the secondary structure of this motif and of the side chain attached to the TCA and it is not specific to PrPC. Because biologically inactive 9-aminoacridine (9-aa) binds with similar K-D as anti-prion active quinacrine, direct interaction with PrPC as mechanism of action appears highly unlikely. However, binding of 9-aa to Ar-Ar-motifs in proteins can be used as reporter for biological macromolecule interactions, by measuring changes in T-1-NMR relaxation times of 9-aa.
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
588 _ _ |a Dataset connected to Web of Science
650 _ 7 |2 WoSType
|a J
653 2 0 |2 Author
|a Conformational disease
653 2 0 |2 Author
|a Prion protein
653 2 0 |2 Author
|a Quinacrine
653 2 0 |2 Author
|a 9-aminoacridine
653 2 0 |2 Author
|a Drug design
653 2 0 |2 Author
|a Ligand binding
653 2 0 |2 Author
|a NMR-spectroscopy
653 2 0 |2 Author
|a in vitro binding assay
653 2 0 |2 Author
|a Relaxation
700 1 _ |0 P:(DE-HGF)0
|a Frank, A.O.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Ziegler, J.
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Klingenstein, R.
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Schweimer, K.
|b 4
700 1 _ |0 P:(DE-Juel1)132029
|a Willbold, D.
|b 5
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Korth, C.
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Rösch, P.
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Schwarzinger, S.
|b 8
773 _ _ |0 PERI:(DE-600)2085732-9
|g Vol. 27, p. 163 - 170
|p 163 - 170
|q 27<163 - 170
|t Journal of biomolecular structure & dynamics
|v 27
|x 0739-1102
|y 2009
909 C O |o oai:juser.fz-juelich.de:6512
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|a DE-HGF
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
914 1 _ |y 2009
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |d 31.12.2010
|g ISB
|k ISB-3
|l Strukturbiochemie
|0 I:(DE-Juel1)VDB942
|x 0
920 1 _ |0 I:(DE-82)080012_20140620
|k JARA-HPC
|l Jülich Aachen Research Alliance - High-Performance Computing
|g JARA
|x 1
970 _ _ |a VDB:(DE-Juel1)114824
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a I:(DE-82)080012_20140620
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)VDB1346


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21